Skip to main content

HB 156 — Kentucky

AN ACT relating to intranasal epinephrine.

Introduced 2026RS session House

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

Amend KRS 158.832 to include intranasal epinephrine to list of medications used to treat anaphylaxis; amend KRS 158.836 to include intranasal epinephrine as permissible for schools to keep.

Official abstract, as published by the legislature.

  • HB 156 is a bill in the Kentucky House, 2026RS session, introduced January 7, 2026.
  • Sponsored by A. Camuel, A. Moore, and G. Brown Jr..
  • Current status: introduced.
  • Most recent action (January 14, 2026): to Health Services (H).
  • Subjects: Children And Minors, Drugs And Medicines, Education, Elementary And Secondary, Health And Medical Services.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: A. Camuel, A. Moore, G. Brown Jr.

History

  1. Introduced, completed
  2. Passed House, in progress
  3. Passed Senate, not reached yet
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. House introduced in House Milestone
  2. House to Committee on Committees (H)
  3. House to Health Services (H) Latest

Source: Open States. Last checked November 11, 2026. How we keep this accurate ›